Telomir Pharmaceuticals Files 8-K: Other Events
Ticker: TELO · Form: 8-K · Filed: Jul 22, 2025 · CIK: 1971532
Sentiment: neutral
Topics: 8-k, other-events
TL;DR
Telomir Pharma filed an 8-K for 'Other Events' on 7/18/25 - details TBD.
AI Summary
On July 18, 2025, Telomir Pharmaceuticals, Inc. filed an 8-K report. The filing indicates an 'Other Events' item, but provides no further specific details regarding the nature of these events, any associated parties, or financial implications within the provided text.
Why It Matters
This filing signals that Telomir Pharmaceuticals has reported significant events to the SEC, but the lack of detail requires further investigation to understand the implications for the company.
Risk Assessment
Risk Level: medium — The filing indicates 'Other Events' without providing specifics, creating uncertainty about potential material impacts on the company.
Key Players & Entities
- Telomir Pharmaceuticals, Inc. (company) — Registrant
- July 18, 2025 (date) — Date of earliest event reported
- Florida (location) — State of Incorporation
- Miami, Florida (location) — Address of Principal Executive Offices
- (786) 396-6723 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by Telomir Pharmaceuticals, Inc.?
The provided text of the 8-K filing does not specify the nature of the 'Other Events'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 18, 2025.
Where is Telomir Pharmaceuticals, Inc. headquartered?
The company's principal executive offices are located at 100 SE 2nd St, Suite 2000, #1009, Miami, Florida.
What is the SEC file number for Telomir Pharmaceuticals, Inc.?
The SEC file number is 001-41952.
What is the IRS Employer Identification Number for Telomir Pharmaceuticals, Inc.?
The IRS Employer Identification Number is 87-2606031.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 22, 2025 regarding Telomir Pharmaceuticals, Inc. (TELO).